Dextech Medical AB reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was SEK 0.879 million compared to SEK 3.03 million a year ago. Net loss was SEK 1.08 million compared to SEK 1.2 million a year ago. Basic loss per share from continuing operations was SEK 0.06 compared to SEK 0.06 a year ago.
For the six months, sales was SEK 2.53 million compared to SEK 3.98 million a year ago. Net loss was SEK 1.99 million compared to SEK 2.01 million a year ago. Basic loss per share from continuing operations was SEK 0.11 compared to SEK 0.11 a year ago.